PD
Point72 (DIFC) Portfolio holdings
AUM
$1.25B
1-Year Return
9.31%
This Quarter Return
-0.11%
1 Year Return
+9.31%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$1.13B
AUM Growth
-$166M
(-13%)
Cap. Flow
-$153M
Cap. Flow
% of AUM
-13.54%
Top 10 Holdings %
Top 10 Hldgs %
21.99%
Holding
1,563
New
550
Increased
143
Reduced
166
Closed
561
Top Buys
| 1 |
Apple
AAPL
|
+$33.9M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$26.6M |
| 3 |
Spotify
SPOT
|
+$26.4M |
| 4 |
Amazon
AMZN
|
+$25.2M |
| 5 |
RTX Corp
RTX
|
+$24.8M |
Top Sells
| 1 |
Oracle
ORCL
|
+$35.4M |
| 2 |
Meta Platforms (Facebook)
META
|
+$24.6M |
| 3 |
Uber
UBER
|
+$23.9M |
| 4 |
SPDR S&P 500 ETF Trust
SPY
|
+$23.6M |
| 5 |
Progressive
PGR
|
+$21.6M |
Sector Composition
| 1 | Technology | 19.64% |
| 2 | Industrials | 15.95% |
| 3 | Financials | 14.78% |
| 4 | Healthcare | 14.11% |
| 5 | Consumer Discretionary | 11.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
626
ESS Tech
GWH
$20.8M
| $32.1K | ﹤0.01% |
+2,613
| New | +$32.1K |
|
|
NXRT
627
NexPoint Residential Trust
NXRT
$850M
| $31.6K | ﹤0.01% |
+800
| New | +$31.6K |
|
628
AngioDynamics
ANGO
$445M
| $31.5K | ﹤0.01% |
5,206
-3,563
| -41% | -$21.6K |
|
629
Karyopharm Therapeutics
KPTI
$53.8M
| $31.2K | ﹤0.01% |
+2,396
| New | +$31.2K |
|
630
Douglas Elliman
DOUG
$230M
| $30.6K | ﹤0.01% |
26,343
+25,421
| +2,757% | +$29.5K |
|
631
Candel Therapeutics
CADL
$266M
| $30.5K | ﹤0.01% |
+4,927
| New | +$30.5K |
|
632
Unisys
UIS
$276M
| $30.4K | ﹤0.01% |
+7,353
| New | +$30.4K |
|
633
DHI Group
DHX
$143M
| $30.3K | ﹤0.01% |
+14,482
| New | +$30.3K |
|
|
BORR
634
Borr Drilling
BORR
$884M
| $29.7K | ﹤0.01% |
+4,599
| New | +$29.7K |
|
|
GRTS
635
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
| $29.4K | ﹤0.01% |
+47,648
| New | +$29.4K |
|
636
Portillo's
PTLO
$442M
| $29.3K | ﹤0.01% |
+3,018
| New | +$29.3K |
|
637
Forrester Research
FORR
$188M
| $29.3K | ﹤0.01% |
1,713
+658
| +62% | +$11.2K |
|
638
Citius Pharmaceuticals
CTXR
$20.6M
| $29.1K | ﹤0.01% |
+1,993
| New | +$29.1K |
|
|
NVRO
639
DELISTED
NEVRO CORP.
NVRO
| $28.6K | ﹤0.01% |
3,400
-4,120
| -55% | -$34.7K |
|
640
Microvast
MVST
$916M
| $28.3K | ﹤0.01% |
+62,015
| New | +$28.3K |
|
|
MRNS
641
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| $27.7K | ﹤0.01% |
+23,698
| New | +$27.7K |
|
642
Cardiff Oncology
CRDF
$136M
| $27.3K | ﹤0.01% |
+12,284
| New | +$27.3K |
|
|
BDN
643
Brandywine Realty Trust
BDN
$761M
| $27.2K | ﹤0.01% |
+6,078
| New | +$27.2K |
|
644
LendingTree
TREE
$977M
| $26.9K | ﹤0.01% |
648
-6,130
| -90% | -$255K |
|
645
Heritage Financial
HFWA
$842M
| $26.9K | ﹤0.01% |
+1,490
| New | +$26.9K |
|
646
Metropolitan Bank Holding Corp
MCB
$813M
| $26.9K | ﹤0.01% |
+638
| New | +$26.9K |
|
647
SpartanNash
SPTN
$900M
| $26.8K | ﹤0.01% |
1,430
-7,439
| -84% | -$140K |
|
648
RAPT Therapeutics
RAPT
$234M
| $26.5K | ﹤0.01% |
1,087
-5,354
| -83% | -$131K |
|
649
Forward Air
FWRD
$913M
| $26.4K | ﹤0.01% |
+1,386
| New | +$26.4K |
|
650
HCI Group
HCI
$2.31B
| $26.2K | ﹤0.01% |
+284
| New | +$26.2K |
|